Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-47.1%
5Y CAGR-35.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-47.1%/yr
vs +108.1%/yr prior
5Y CAGR
-35.4%/yr
Recent deceleration
Acceleration
-155.2pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $95.71M | +47.9% |
| 2024 | $64.70M | -55.0% |
| 2023 | $143.82M | -77.8% |
| 2022 | $646.71M | -15.4% |
| 2021 | $764.38M | -10.1% |
| 2020 | $850.12M | +3824.6% |
| 2019 | $21.66M | -37.2% |
| 2018 | $34.49M | - |